[Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis]. 1999

P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
Dermatologische Klinik der Ruhr-Universität, Bochum im St.Josef-Hospital, Bochum.

We examined whether it is possible to increase the antipsoriatic action by combining dithranol with a retinoid (tazarotene). In a randomized, open, prospective study with 50 psoriatic patients (22 females, 28 males, PASI>10) the antipsoriatic effectiveness of dithranol monotherapy to was compared combined therapy with dithranol and retinoid. The combination dithranol/retinoid (collective 2, reduction of the PASI from 17,2 to 2,8) revealed a significantly faster healing than the dithranol monotherapy (collective 1, reduction of the PASI from 18,5 to 4,8). The irritation of the combination therapy as evaluated with clinical score and laser doppler imaging was increased. Anti-psoriatic effectiveness of dithranol can be increased by combining it with tazarotene.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females

Related Publications

P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
September 1975, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
September 1975, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
July 1994, Acta dermato-venereologica,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
April 1998, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
August 1999, Contact dermatitis,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
October 1982, Dermatologica,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
January 1984, Arzneimittel-Forschung,
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
March 1979, Lancet (London, England),
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
March 1979, Lancet (London, England),
P Sander, and M Happe, and M Stücker, and N Hermes, and K Hoffmann, and P Altmeyer
August 1978, European journal of clinical investigation,
Copied contents to your clipboard!